# Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action

> **NCT01990898** · PHASE2 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 26 (actual)

## Conditions studied

- Interstitial Cystitis

## Interventions

- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT01990898
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-10
- **Final completion:** 2016-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01990898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01990898, "Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01990898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*